Gerasimos Siasos

About Gerasimos Siasos

Gerasimos Siasos, With an exceptional h-index of 62 and a recent h-index of 41 (since 2020), a distinguished researcher at National and Kapodistrian University of Athens, specializes in the field of atherosclerosis, cardiovascular medicine, endothelial function, molecular cardiology, vascular.

His recent articles reflect a diverse array of research interests and contributions to the field:

Unveiling the Role of Endothelial Dysfunction: A Possible Key to Enhancing Catheter Ablation Success in Atrial Fibrillation

Anticoagulation in Patients with Atrial High-rate Episodes Detected by Cardiac Implantable Electronic Devices.

Expression of Circulating miR-21 and-29 and their Association with Myocardial Fibrosis in Hypertrophic Cardiomyopathy.

Long COVID-19 Syndrome and Sudden Cardiac Death: The Phantom Menace

Renal Congestion in Heart Failure: Insights in Novel Diagnostic Modalities

Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic …

Interleukin-6 signaling in atherosclerosis: from molecular mechanisms to clinical outcomes

Advances in heart failure with preserved ejection fraction management-the role of sacubitril-valsartan, pirfenidone, spironolactone and empagliflozin: is success a series of …

Gerasimos Siasos Information

University

Position

Medical School Harvard University

Citations(all)

16375

Citations(since 2020)

11239

Cited By

8538

hIndex(all)

62

hIndex(since 2020)

41

i10Index(all)

234

i10Index(since 2020)

175

Email

University Profile Page

Google Scholar

Gerasimos Siasos Skills & Research Interests

atherosclerosis

cardiovascular medicine

endothelial function

molecular cardiology

vascular

Top articles of Gerasimos Siasos

Unveiling the Role of Endothelial Dysfunction: A Possible Key to Enhancing Catheter Ablation Success in Atrial Fibrillation

2024/2/15

Anticoagulation in Patients with Atrial High-rate Episodes Detected by Cardiac Implantable Electronic Devices.

Current Pharmaceutical Design

2024/2/1

Gerasimos Siasos
Gerasimos Siasos

H-Index: 32

Expression of Circulating miR-21 and-29 and their Association with Myocardial Fibrosis in Hypertrophic Cardiomyopathy.

Current Medicinal Chemistry

2024

Long COVID-19 Syndrome and Sudden Cardiac Death: The Phantom Menace

Current Medicinal Chemistry

2024/1/1

Gerasimos Siasos
Gerasimos Siasos

H-Index: 32

Renal Congestion in Heart Failure: Insights in Novel Diagnostic Modalities

2024/2/29

Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic …

2024/2/23

Interleukin-6 signaling in atherosclerosis: from molecular mechanisms to clinical outcomes

2023/9/1

Advances in heart failure with preserved ejection fraction management-the role of sacubitril-valsartan, pirfenidone, spironolactone and empagliflozin: is success a series of …

2023/2/1

Georgios Giannopoulos
Georgios Giannopoulos

H-Index: 5

Gerasimos Siasos
Gerasimos Siasos

H-Index: 32

The Role of Shear Stress in Coronary Artery Disease

2023/9/1

Gerasimos Siasos
Gerasimos Siasos

H-Index: 32

Evangelos Oikonomou
Evangelos Oikonomou

H-Index: 27

Metabolic Syndrome and Atrial Fibrillation: Different Entities or Combined Disorders

2023/8/28

Evangelos Oikonomou
Evangelos Oikonomou

H-Index: 27

Gerasimos Siasos
Gerasimos Siasos

H-Index: 32

Lipoprotein (a) in atherosclerotic diseases: from pathophysiology to diagnosis and treatment

2023/1/18

Diffuse LAD and LV thrombus as possible manifestation of protein-S deficiency in a young patient

Case Reports

2023/8/16

Net clinical benefit of DOACs vs. usual anticoagulation treatment in venous thromboembolism and active cancer: systematic review and meta-analysis

2023/1

Gerasimos Siasos
Gerasimos Siasos

H-Index: 32

Exercise Effects on Left Ventricular Remodeling in Patients with Cardiometabolic Risk Factors

2023/8/14

Semaglutide and cardiovascular outcomes in obesity without diabetes

New England Journal of Medicine

2023/12/14

Antiarrhythmic Potential of Epicardial Botulinum Toxin Injection for Suppression of Postoperative Atrial Fibrillation.

Current Molecular Pharmacology

2023/8/1

Dimitrios Iliopoulos
Dimitrios Iliopoulos

H-Index: 15

Gerasimos Siasos
Gerasimos Siasos

H-Index: 32

Inherited arrhythmias and gene therapy: Are there any ethical considerations to take into account?

World Journal of Cardiology

2023/12/12

Gerasimos Siasos
Gerasimos Siasos

H-Index: 32

The prognostic role of galectin-3 and endothelial function in patients with heart failure

Cardiology Journal

2023

The Role of Right Ventriculo–Arterial Coupling in Symptoms Presentation of Patients with Hypertrophic Cardiomyopathy

Journal of Clinical Medicine

2023/7/20

Diabetes Mellitus in Acute Coronary Syndrome

2023/11/19

See List of Professors in Gerasimos Siasos University(National and Kapodistrian University of Athens)

Co-Authors

academic-engine